Skip to main content
. Author manuscript; available in PMC: 2011 Mar 8.
Published in final edited form as: Patient. 2010;3(4):229–248. doi: 10.2165/11539470-000000000-00000

Table II.

Simplified balance sheet after removal of the dominated option

Drug Effectiveness Risk of Adverse Effects Cost

Symptom relief Halt disease progression Reported rate of serious
side effects
Reported rate of
common side effects
Monthly out-of-
pocket cost

Response
rate
Ranking Response
rate
Ranking Rate Ranking Rate Ranking Cost Ranking

A 95% 1 65% 3 0.1% 1 1% 1 $15 1

B1 90% 2 75% 2 0.5% 2 5% 2 $50 2

C 85% 3 85% 1 1% 3 10% 3 $100 3